Viatris closes acquisition of 2 life sciences companies

Healthcare company Viatris closed its $415 million acquisition of Oyster Point Pharma and its $280 million acquisition of Famy Life Sciences. 

Advertisement

The acquisitions will form Viatris Eye Care Division. Viatris first announced the moves Nov. 7, according to a Jan. 3 Viatris news release.

Viatris is looking for the new division to power a potential $1 billion in new sales by 2028.

“With this combination we are well on our way to expand our portfolio and commercial footprint and create a global eye care leader,” Jeffry Nau, PhD, head of the Viatris Eye Care Division, said in the release. “We believe that a new leader in the space can meaningfully shape the future of eye care to address the unmet needs of patients with ophthalmic disease and the eye care professionals who take care of them.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Disruptors

  • OpenAI signed its first international hospital partnership with Ramat Gan, Israel-based Sheba Medical Center. The deal, according to a July…

  • Microsoft is continuing to hire for health tech roles including a forward deployed AI engineer position tied to its healthcare…

  • Amazon is hiring software and applied-science leaders, AI engineers and a healthcare cybersecurity specialist — the kinds of roles hospital…

Advertisement

Comments are closed.